Here's Why Ipsen S.A. Just Paid €700M For Memo Therapeutics AG
AI Summary
Ipsen S.A. acquired Memo Therapeutics AG for €700 million, marking a significant investment in the biotech sector. This deal is part of Ipsen's strategic expansion in innovative therapeutic areas.